PROJECT

Remote monitoring of heart failure patients

Need

Remote patient monitoring (RPM) plays a critical role in managing heart failure. Traditional methods—such as checking symptoms and tracking weight or blood pressure through phone calls or clinic visits—have important limitations. By the time noticeable symptoms appear, the condition may already have worsened to the point where hospitalization is difficult to prevent.

These acute decompensation episodes are distressing for patients, causing major disruptions to daily life. In addition, each decompensation can further weaken heart function, contributing to a gradual, long-term decline in health and increasing damage to vital organs.

RPM using intravascular devices has shown potential to reduce rehospitalizations. However, they still miss over 60% of rehospitalizations and 75% of deaths. These platforms measure only one parameter of this highly complex condition, preventing a deep understanding of the reason for the decompensation and hindering appropriate medication adjustments.

Our solution: Patient- & event-specific proactive care

FORESEE is developing a novel multiparametric intravascular sensor for RPM of heart failure. It is based in an innovative powering and communication technology that avoids the use of bulky components within the implant. Our intravascular device is wirelessly powered using the human body as an electrical conductor of energy supplied by an external unit using a vest. This method allows us to power the electronics of the battery-less implant and communicate with it to define which parameters to measure and how to measure them.

Each morning, patients will take a single 5-minute measurement from home. The data will be sent to clinicians and alerts will trigger if early signs of decompensation are detected. With the information provided, healthcare professionals will have an instant and complete view of the patient’s condition and will be able to make a proactive adjustment of medication.

FORESEE has secured €2.5 million in non-dilutive funding through the
European Innovation Council (EIC) Transition grant